日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

[Corrigendum] RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling

【更正】RIPK4/PEBP1轴通过激活RAF1/MEK/ERK信号通路促进胰腺癌细胞迁移和侵袭

Qi, Zi-Hao; Xu, Hua-Xiang; Zhang, Shi-Rong; Xu, Jin-Zhi; Li, Shuo; Gao, He-Li; Jin, Wei; Wang, Wen-Quan; Wu, Chun-Tao; Ni, Quan-Xing; Yu, Xian-Jun; Liu, Liang

GUIDE: a prospective cohort study for blood-based early detection of gastrointestinal cancers using targeted DNA methylation and fragmentomics sequencing.

GUIDE:一项基于血液的前瞻性队列研究,利用靶向 DNA 甲基化和片段组学测序技术早期检测胃肠道癌症

Huang Ao, Guo De-Zhen, Su Zhi-Xi, Zhong Yun-Shi, Liu Liang, Xiong Zhi-Guo, He Dong-Li, Yan Bin, Li Quan-Lin, Feng Zhen, Wang Wen-Quan, Lu Pin-Xiang, He Meng-Jiang, Qi Zhi-Peng, Guo Qi, Cheng Jian-Wen, Zhang Shi-Yu, Guo Wei, Li Qing, Lin Guo-Yong, Sun Hui-Chuan, Qiu Shuang-Jian, He Qi-Ye, Fan Jia, Goel Ajay, Liu Rui, Jin Gang, Yang Xin-Rong, Zhou Jian

Impact of external drainage of the main pancreatic duct and common bile duct on postoperative pancreatic fistula following pancreatoduodenectomy: protocol for a multicentre randomized clinical trial

胰十二指肠切除术后主胰管和胆总管外引流对术后胰瘘的影响:一项多中心随机临床试验方案

Wang, Wen-Quan; Xu, Yao-Lin; Tang, Lin-Hui; He, Jun-Yi; Li, Yu; Liang, Fei; Zhang, Yue-Ming; Gan, Wei; Xu, Hua-Xiang; Zhang, Lei; Wu, Wen-Chuan; Shi, Chen-Ye; Jin, Yun; Jiang, Chong-Yi; Wang, Zheng; He, Min; Wang, Xu-An; Qiu, Yu-Dong; Liu, Liang

First reported advanced pancreatic cancer with hyperprogression treated with PD-1 blockade combined with chemotherapy: a case report and literature review

首例采用PD-1阻断联合化疗治疗的伴有超进展的晚期胰腺癌病例报告及文献综述

Wang, Ya-Zhou; Peng, Mao-Zhen; Xu, Yao-Lin; Ying, Ying; Tang, Lin-Hui; Xu, Hua-Xiang; He, Jun-Yi; Liu, Liang; Wang, Wen-Quan

Comment on: Are Parenchyma-Sparing Resections Really Appropriate for Small (<3 cm) Nonfunctional Pancreatic Neuroendocrine Tumors?

评论:对于小型(<3 cm)无功能性胰腺神经内分泌肿瘤,保留实质的切除术真的合适吗?

Peng, Mao-Zhen; Ying, Ying; Lou, Wen-Hui; Liu, Liang; Wang, Wen-Quan

Neoadjuvant chemotherapy endows CD9 with prognostic value that differs between tumor and stromal areas in patients with pancreatic cancer

新辅助化疗赋予CD9预后价值,这种价值在胰腺癌患者的肿瘤和间质区域有所不同。

Han, Xuan; Zhang, Wu-Hu; Gao, He-Li; Li, Tian-Jiao; Xu, Hua-Xiang; Li, Hao; Li, Peng-Cheng; Wang, Xu; Yu, Xian-Jun; Wang, Wen-Quan; Liu, Liang

Identification of characteristic markers correlated with Th2 cell infiltration and metabolism molecular subtype in pancreatic adenocarcinoma

胰腺腺癌中与Th2细胞浸润和代谢分子亚型相关的特征性标志物的鉴定

Xu, Zi-Jin; Li, Peng-Cheng; Wang, Wen-Quan; Liu, Liang

Advances on diagnostic biomarkers of pancreatic ductal adenocarcinoma: A systems biology perspective

胰腺导管腺癌诊断生物标志物的研究进展:系统生物学视角

Zhang, Wu-Hu; Wang, Wen-Quan; Han, Xuan; Gao, He-Li; Li, Tian-Jiao; Xu, Shuai-Shuai; Li, Shuo; Xu, Hua-Xiang; Li, Hao; Ye, Long-Yun; Lin, Xuan; Wu, Chun-Tao; Long, Jiang; Yu, Xian-Jun; Liu, Liang

Tumor-infiltrating platelets predict postoperative recurrence and survival in resectable pancreatic neuroendocrine tumor

肿瘤浸润血小板可预测可切除胰腺神经内分泌肿瘤术后的复发和生存情况

Xu, Shuai-Shuai; Xu, Hua-Xiang; Wang, Wen-Quan; Li, Shuo; Li, Hao; Li, Tian-Jiao; Zhang, Wu-Hu; Liu, Liang; Yu, Xian-Jun

SRPX2 and RAB31 are effective prognostic biomarkers in pancreatic cancer

SRPX2和RAB31是胰腺癌的有效预后生物标志物

Li, Hao; Zhang, Shi-Rong; Xu, Hua-Xiang; Wang, Wen-Quan; Li, Shuo; Li, Tian-Jiao; Ni, Quan-Xing; Yu, Xian-Jun; Liu, Liang; Wu, Chun-Tao